Literature DB >> 18490617

Natural history of spinal-bulbar muscular atrophy.

Nizar Chahin1, Christopher Klein, Jayawant Mandrekar, Eric Sorenson.   

Abstract

BACKGROUND: Although spinal-bulbar muscular atrophy (SBMA) is generally believed to be associated with better survival and function compared to other motor neuron diseases, no systematic study of long-term functional status or survival has been reported.
METHODS: We report the results a retrospective review of 39 patients with genetically confirmed diagnosis and compared their survival to normal, population-based, age- and gender-matched controls. We assessed the functional status of 25 of the 33 survivors by completing the revised ALS Functional Rating Scale (ALSFRS-r) by telephone.
RESULTS: The subjects with SBMA had a 10-year survival of 82% compared to 95% among the age-matched controls (p = 0.053). The mean ALSFRS-r score for the survivors was 37 (range 27-43). The ALSFRS-r subscores indicated mild deficits in all areas in most, with the greatest limitation being the use of stairs. While all reported bulbar symptoms, none had disabling deficits. None of the subjects required a percutaneous endoscopic gastrostomy tube and one subject used noninvasive positive pressure ventilation.
CONCLUSIONS: The long-term survival of subjects with spinal-bulbar muscular atrophy is minimally reduced from their age-matched controls. The long-term functional assessments demonstrate mild neurologic impairment in most without devastating bulbar or respiratory dysfunction and good ambulatory function years after diagnosis.

Entities:  

Mesh:

Year:  2008        PMID: 18490617     DOI: 10.1212/01.wnl.0000312510.49768.eb

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Absence of disturbed axonal transport in spinal and bulbar muscular atrophy.

Authors:  Bilal Malik; Niranjanan Nirmalananthan; Lynsey G Bilsland; Albert R La Spada; Michael G Hanna; Giampietro Schiavo; Jean-Marc Gallo; Linda Greensmith
Journal:  Hum Mol Genet       Date:  2011-02-11       Impact factor: 6.150

2.  Brain MRI shows white matter sparing in Kennedy's disease and slow-progressing lower motor neuron disease.

Authors:  Edoardo G Spinelli; Federica Agosta; Pilar M Ferraro; Giorgia Querin; Nilo Riva; Cinzia Bertolin; Ilaria Martinelli; Christian Lunetta; Andrea Fontana; Gianni Sorarù; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2019-03-28       Impact factor: 5.038

Review 3.  Emergencies in motoneuron disease.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Intern Emerg Med       Date:  2017-03-09       Impact factor: 3.397

4.  Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.

Authors:  Lindsay E Fernández-Rhodes; Angela D Kokkinis; Michelle J White; Charlotte A Watts; Sungyoung Auh; Neal O Jeffries; Joseph A Shrader; Tanya J Lehky; Li Li; Jennifer E Ryder; Ellen W Levy; Beth I Solomon; Michael O Harris-Love; Alison La Pean; Alice B Schindler; Cheunju Chen; Nicholas A Di Prospero; Kenneth H Fischbeck
Journal:  Lancet Neurol       Date:  2011-01-06       Impact factor: 44.182

5.  Disorders of sleep in spinal and bulbar muscular atrophy (Kennedy's disease).

Authors:  Lisa Langenbruch; Salvador Perez-Mengual; Christian Glatz; Peter Young; Matthias Boentert
Journal:  Sleep Breath       Date:  2020-11-21       Impact factor: 2.816

6.  Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity.

Authors:  Wooi F Lim; Mitra Forouhan; Thomas C Roberts; Jesse Dabney; Ruth Ellerington; Alfina A Speciale; Raquel Manzano; Maria Lieto; Gavinda Sangha; Subhashis Banerjee; Mariana Conceição; Lara Cravo; Annabelle Biscans; Loïc Roux; Naemeh Pourshafie; Christopher Grunseich; Stephanie Duguez; Anastasia Khvorova; Maria Pennuto; Constanza J Cortes; Albert R La Spada; Kenneth H Fischbeck; Matthew J A Wood; Carlo Rinaldi
Journal:  Sci Adv       Date:  2021-08-20       Impact factor: 14.136

7.  Standard and modified statistical MUNE evaluations in spinal-bulbar muscular atrophy.

Authors:  Tanya J Lehky; Cheun Ju Chen; Nicholas A di Prospero; Lindsay E Rhodes; Kenneth Fischbeck; Mary Kay Floeter
Journal:  Muscle Nerve       Date:  2009-11       Impact factor: 3.217

8.  Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure.

Authors:  Giorgia Querin; Elisa DaRe; Ilaria Martinelli; Luca Bello; Cinzia Bertolin; Davide Pareyson; Caterina Mariotti; Elena Pegoraro; Gianni Sorarù
Journal:  Neurol Sci       Date:  2016-07-21       Impact factor: 3.307

9.  Fighting polyglutamine disease by wrestling with SUMO.

Authors:  Tim J Craig; Jeremy M Henley
Journal:  J Clin Invest       Date:  2015-01-20       Impact factor: 14.808

10.  Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy.

Authors:  Bilal Malik; Niranjanan Nirmalananthan; Anna L Gray; Albert R La Spada; Michael G Hanna; Linda Greensmith
Journal:  Brain       Date:  2013-02-07       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.